639 related articles for article (PubMed ID: 29204955)
1. The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis.
Freedman SN; Shahi SK; Mangalam AK
Neurotherapeutics; 2018 Jan; 15(1):109-125. PubMed ID: 29204955
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiome in multiple sclerosis: The players involved and the roles they play.
Shahi SK; Freedman SN; Mangalam AK
Gut Microbes; 2017 Nov; 8(6):607-615. PubMed ID: 28696139
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives.
Chu F; Shi M; Lang Y; Shen D; Jin T; Zhu J; Cui L
Mediators Inflamm; 2018; 2018():8168717. PubMed ID: 29805314
[TBL] [Abstract][Full Text] [Related]
4. Interactions between host genetics and gut microbiota determine susceptibility to CNS autoimmunity.
Montgomery TL; Künstner A; Kennedy JJ; Fang Q; Asarian L; Culp-Hill R; D'Alessandro A; Teuscher C; Busch H; Krementsov DN
Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27516-27527. PubMed ID: 33077601
[TBL] [Abstract][Full Text] [Related]
5. Intestinal Dysbiosis and Tryptophan Metabolism in Autoimmunity.
Brown J; Robusto B; Morel L
Front Immunol; 2020; 11():1741. PubMed ID: 32849620
[TBL] [Abstract][Full Text] [Related]
6. Direct and indirect effects of microbiota-derived metabolites on neuroinflammation in multiple sclerosis.
Fettig NM; Osborne LC
Microbes Infect; 2021; 23(6-7):104814. PubMed ID: 33775860
[TBL] [Abstract][Full Text] [Related]
7. Impacts of microbiome metabolites on immune regulation and autoimmunity.
Haase S; Haghikia A; Wilck N; Müller DN; Linker RA
Immunology; 2018 Jun; 154(2):230-238. PubMed ID: 29637999
[TBL] [Abstract][Full Text] [Related]
8. Short-chain fatty acids and gut microbiota in multiple sclerosis.
Melbye P; Olsson A; Hansen TH; Søndergaard HB; Bang Oturai A
Acta Neurol Scand; 2019 Mar; 139(3):208-219. PubMed ID: 30427062
[TBL] [Abstract][Full Text] [Related]
9. The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?
Parodi B; Kerlero de Rosbo N
Front Immunol; 2021; 12():718220. PubMed ID: 34621267
[TBL] [Abstract][Full Text] [Related]
10. The Dynamics of the Gut Microbiome in Multiple Sclerosis in Relation to Disease.
Mowry EM; Glenn JD
Neurol Clin; 2018 Feb; 36(1):185-196. PubMed ID: 29157399
[TBL] [Abstract][Full Text] [Related]
11. Interaction of the Gut Microbiome and Immunity in Multiple Sclerosis: Impact of Diet and Immune Therapy.
Yadav SK; Ito K; Dhib-Jalbut S
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834203
[TBL] [Abstract][Full Text] [Related]
12. Role of Gut Microbiota in Multiple Sclerosis and Potential Therapeutic Implications.
Wang X; Liang Z; Wang S; Ma D; Zhu M; Feng J
Curr Neuropharmacol; 2022; 20(7):1413-1426. PubMed ID: 34191698
[TBL] [Abstract][Full Text] [Related]
13. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
Rizzetto L; Fava F; Tuohy KM; Selmi C
J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
[TBL] [Abstract][Full Text] [Related]
14. Does the Gut Microbiota Influence Immunity and Inflammation in Multiple Sclerosis Pathophysiology?
Adamczyk-Sowa M; Medrek A; Madej P; Michlicka W; Dobrakowski P
J Immunol Res; 2017; 2017():7904821. PubMed ID: 28316999
[No Abstract] [Full Text] [Related]
15. Diet-microbiome-immune interplay in multiple sclerosis: Understanding the impact of phytoestrogen metabolizing gut bacteria.
Lehman PC; Ghimire S; Price JD; Ramer-Tait AE; Mangalam AK
Eur J Immunol; 2023 Nov; 53(11):e2250236. PubMed ID: 37673213
[TBL] [Abstract][Full Text] [Related]
16. Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosis.
Calvo-Barreiro L; Eixarch H; Montalban X; Espejo C
Autoimmun Rev; 2018 Feb; 17(2):165-174. PubMed ID: 29191793
[TBL] [Abstract][Full Text] [Related]
17. Emerging Concepts on the Gut Microbiome and Multiple Sclerosis.
Glenn JD; Mowry EM
J Interferon Cytokine Res; 2016 Jun; 36(6):347-57. PubMed ID: 27145057
[TBL] [Abstract][Full Text] [Related]
18. Host Genetics and Gut Microbiome: Perspectives for Multiple Sclerosis.
Maglione A; Zuccalà M; Tosi M; Clerico M; Rolla S
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440354
[TBL] [Abstract][Full Text] [Related]
19. Dietary ellagic acid therapy for CNS autoimmunity: Targeting on Alloprevotella rava and propionate metabolism.
Han B; Shi L; Bao MY; Yu FL; Zhang Y; Lu XY; Wang Y; Li DX; Lin JC; Jia W; Li X; Zhang Y
Microbiome; 2024 Jun; 12(1):114. PubMed ID: 38915127
[TBL] [Abstract][Full Text] [Related]
20. A bidirectional association between the gut microbiota and CNS disease in a biphasic murine model of multiple sclerosis.
Colpitts SL; Kasper EJ; Keever A; Liljenberg C; Kirby T; Magori K; Kasper LH; Ochoa-Repáraz J
Gut Microbes; 2017 Nov; 8(6):561-573. PubMed ID: 28708466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]